Tier 2 — strong
Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults
European journal of nutrition
2021
60(4):1921-1934
Bibliography
- PubMed
- PMID 32918135
- PubMed Central
- PMC7947037
- Funding
- Indexed grant support: K99 ES030400 — NIEHS NIH HHS — United States; R01 CA133595 — NCI NIH HHS — United States; R00 ES018890 — NIEHS NIH HHS — United States; P42 ES010349 — NIEHS NIH HHS — United States; T32 ES007322 — NIEHS NIH HHS — United States; TL1 TR001875 — NCATS NIH HHS — United States; R01 ES017875 — NIEHS NIH HHS — United States; P30 ES009089 — NIEHS NIH HHS — United States; F31 ES029019 — NIEHS NIH HHS — United States; R01 ES030945 — NIEHS NIH HHS — United States. The indexed list may not contain the complete funding declaration.
- Competing interests
- Reported disclosure: /Competing interests: The authors declare that they have no conflicts of interest or competing interests.
Study snapshot
| Design | RCT secondary analysis |
|---|---|
| Model | Human participants |
| Sample | 622 arsenic-exposed Bangladeshi adults |
| Intervention | Folic acid and/or creatine versus placebo; baseline betaine/choline status examined |
| Duration | 12 weeks |
| Endpoints | Arsenic methylation; Betaine status; Homocysteine |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



